Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma

NCT03116412 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT03116412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03116412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma
Lead sponsor
Uppsala University
Phase
Not applicable
Overall status
Recruiting
Start date
June 8, 2017
Completion date
December 31, 2028
Enrollment
1,300 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma